Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Nov 10:9:1039928.
doi: 10.3389/fmed.2022.1039928. eCollection 2022.

Short-term outcomes of near-infrared imaging using indocyanine green in laparoscopic lateral pelvic lymph node dissection for middle-lower rectal cancer: A propensity score-matched cohort analysis

Jin-Yu Dai  1 , Zhi-Jun Han  1 , Jing-Dong Wang  1 , Bao-Shuang Liu  1 , Jian-Yu Liu  1 , Yan-Cheng Wang  1
Affiliations

Short-term outcomes of near-infrared imaging using indocyanine green in laparoscopic lateral pelvic lymph node dissection for middle-lower rectal cancer: A propensity score-matched cohort analysis

Jin-Yu Dai et al. Front Med (Lausanne). .

Abstract

Laparoscopic lateral pelvic lymph node dissection (LPND) is limited by complex neurovascular bundles in the narrow pelvic sidewall and various post-operative complications. Indocyanine green (ICG) has been applied to increase the number of harvested lymph nodes and reduce the injury of irrelevant vessels in patients with rectal cancer. However, few studies on the recurrence rate of ICG fluorescence imaging-guided laparoscopic LPND were reported. This retrospective study enrolled 50 middle- low rectal cancer patients who were treated by LPND. After propensity score matching, 20 patients were matched in each of the indocyanine green (ICG) guided imaging group (ICG group) and non-ICG guided imaging group (non-ICG group). The average follow-up time was 13.5 months (12-15 months). Our results showed that the total number of harvested lymph nodes in the ICG group was significantly higher than that in the non-ICG group (P < 0.05), and intraoperative blood loss and post-operative hospital stay times in the ICG group were less than those in the non-ICG group (P < 0.05). After 12 months of follow-up, no residual lymph node and local tumor recurrence were found for patients in the ICG group. Four patients in the non-ICG group detected residual lymph nodes at the 3-month visit. Our findings highlighted the importance of ICG fluorescence-guided imaging in LPND because it has unique advantages in improving the number of lymph node dissections, surgical accuracy, and decreasing the residual lymph nodes and local tumor recurrence. In addition, ICG fluorescence guidance technology can effectively shorten the operation time, and it is simple to operate, which is worth popularizing.

Keywords: 3D laparoscopic technology; indocyanine green; lateral pelvic lymph node dissection (LPLD); post-operative complications; rectal cancer.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

References

    1. Takahashi T, Ueno M, Azekura K, Ohta H. Lateral node dissection and total mesorectal excision for rectal cancer. Dis Colon Rectum. (2000) 43:S59–68. 10.1007/BF02237228 - DOI - PubMed
    1. Ohya H, Watanabe J, Suwa H, Suwa Y, Ozawa M, Ishibe A, et al. . Near-infrared imaging using indocyanine green for laparoscopic lateral pelvic lymph node dissection for clinical stage II/III middle-lower rectal cancer: a propensity score-matched cohort study. Dis Colon Rectum. (2022) 65:885–93. 10.1097/DCR.0000000000002156 - DOI - PubMed
    1. Sauer R, Becker H, Hohenberger W, Rodel C, Wittekind C, Fietkau R, et al. . Pre-operative versus post-operative chemoradiotherapy for rectal cancer. N Engl J Med. (2004) 351:1731–40. 10.1056/NEJMoa040694 - DOI - PubMed
    1. Duzova M, Basaran H, Inan G, Gul OV, Eren OO, Korez MK. Pre-operative versus pos-toperative chemoradiotherapy for locally advanced rectal cancer: outcomes of survival, toxicity, sphincter preserving and prognostic factors. Transpl Immunol. (2021) 69:101489. 10.1016/j.trim.2021.101489 - DOI - PubMed
    1. Ogura A, Konishi T, Cunningham C, Garcia-Aguilar J, Iversen H, Toda S, et al. . Neoadjuvant (Chemo)radiotherapy with total mesorectal excision only is not sufficient to prevent lateral local recurrence in enlarged nodes: results of the multicenter lateral node study of patients with low Ct3/4 rectal cancer. J Clin Oncol. (2019) 37:33–43. 10.1200/JCO.18.00032 - DOI - PMC - PubMed

LinkOut - more resources